Carl Zeiss Microscopy, LLC, has announced that it has entered into an agreement with Ultivue Inc. to co-market Ultivue’s multiplex biomarker assays for tissue phenotyping
SAN DIEGO, Nov. 8, 2022 /PRNewswire/ — Leica Biosystems, a technology leader in automated staining and brightfield and fluorescent imaging, has acquired Cell IDx, Inc.,
TEL AVIV, Israel–(BUSINESS WIRE)–Nucleai, a leader in AI-powered spatial biology, today announced the expansion of its spatial biology platform to include a new generation of
Deep Bio, a leading AI biotech dedicated to cancer diagnosis, and Visiopharm, a world leader in AI-powered image analysis and tissue mining for research and
We haven’t yet pulled the wrapper off of our software. Sign up to stay informed.
CellAI | 302-223-9981 | Copyright All Rights Reserved.
